Integra LifeSciences Holdings Corporation EPS Ratio 2011-2026 | IART

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Integra LifeSciences Holdings Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.09	0.85	2.18	2	1.58	0.59	0.73	0.84	1	-0.05	0.52	-0.74	1.46	0.97

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.18	-0.74	0.846

Quarterly EPS Ratio Integra LifeSciences Holdings Corporation

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-6.31	-0.33	-0.14	-0.16	-0.04	0.24	0.05	0.3	-	0.6	0.54	0.39	-	0.51	0.41	0.54	1.1	0.38	-	0.11	0.18	-0.32	0.35	0.38	0.29	0.16	0.14	0.14	0.57	0.04	0.14	0.09	0.38	0.27	0.17	0.18	0.2	-0.45	0.08	0.13	0.53	0.3	0.15	0.07	0.46	-1.09	0.05	-0.22	0.46	0.46	0.3	0.24	0.16	0.39	0.02	0.39

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.1	-6.31	0.0751

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA
Allied Healthcare Products AHPI	-0.48	-	3.58 %	$ 2.21 M	USA
Eargo EAR	-39.7	-	-	$ 10.2 M	USA
Apollo Endosurgery APEN	-0.98	-	-	$ 475 M	USA
Helius Medical Technologies HSDT	-14.6	$ 2.13	-1.39 %	$ 1.29 M	USA
Delcath Systems DCTH	0.08	$ 11.44	3.81 %	$ 410 M	USA
Second Sight Medical Products EYES	-0.43	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	0.89	$ 25.21	-1.6 %	$ 213 M	USA
Avinger AVGR	-23.3	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-1.28	-	-	$ 3.31 B	USA
EDAP TMS S.A. EDAP	-0.51	$ 3.49	4.49 %	$ 131 M	France
Aziyo Biologics AZYO	1.29	-	1.37 %	$ 20.5 M	USA
BioSig Technologies BSGM	-9.65	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	-6.99	-	-	$ 16.4 M	USA
Inspire Medical Systems INSP	4.95	$ 46.15	-15.91 %	$ 1.36 B	USA
ClearPoint Neuro CLPT	-0.9	$ 11.25	0.63 %	$ 319 M	USA
LivaNova PLC LIVN	-4.45	$ 57.82	-2.12 %	$ 3.15 B	Britain
Cardiovascular Systems CSII	-0.94	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	-0.13	$ 0.63	0.87 %	$ 39.2 M	USA
Invacare Corporation IVC	-0.54	-	-	$ 24.7 M	USA
IRIDEX Corporation IRIX	-0.26	$ 1.07	-1.38 %	$ 18.1 M	USA
Dynatronics Corporation DYNT	-1.43	-	14.99 %	$ 929 K	USA
Insulet Corporation PODD	3.51	$ 169.07	-1.35 %	$ 11.9 B	USA
OrthoPediatrics Corp. KIDS	-1.69	$ 16.05	1.71 %	$ 377 M	USA
Sintx Technologies SINT	-6.16	$ 2.38	0.42 %	$ 6.6 M	USA
Butterfly Network BFLY	-0.34	$ 4.96	2.37 %	$ 1.05 B	USA
GBS GBS	-2	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	3.98	$ 91.09	0.54 %	$ 12.3 B	USA
NanoVibronix NAOV	-26.7	-	-	$ 1.08 M	USA
CONMED Corporation CNMD	1.52	$ 36.07	0.45 %	$ 1.12 B	USA
Integer Holdings Corporation ITGR	2.96	$ 86.83	3.36 %	$ 3.02 B	USA
TransMedics Group TMDX	5.6	$ 96.34	-0.76 %	$ 3.27 B	USA
Stryker Corporation SYK	2.21	$ 295.54	1.54 %	$ 113 B	USA
Tandem Diabetes Care TNDM	-0.01	$ 19.25	-3.12 %	$ 1.31 B	USA
Edwards Lifesciences Corporation EW	1.84	$ 82.79	-0.65 %	$ 48.4 B	USA
LENSAR LNSR	-2.87	$ 5.51	-0.9 %	$ 65.9 M	USA
Pulmonx Corporation LUNG	-1.33	$ 1.26	-5.26 %	$ 51.3 M	USA
MiMedx Group MDXG	0.33	$ 3.71	2.77 %	$ 548 M	USA
Myomo MYO	-0.37	$ 0.85	-1.1 %	$ 35.6 M	USA